Ravi is a multi-award winning aesthetic physician with an international reputation for excellence in facial aesthetics and optimising the patient consultation process. He has been a Key Opinion Leader for Nestle Skin Health and Galderma since 2009 and has been instrumental in developing key projects involving the patient journey.
Here’s what Ravi had to say about joining the Cosmecoin advisory board as a Medical Advisor:
“The key to a successful aesthetic and cosmetic surgical practice is high patient satisfaction and loyalty. Surprising to many, this has been shown NOT to dependent just on clinical results but rather a combination of factors all stemming from the initial clinician-patient consultation. The iConsult platform is the first system which provides a framework to assist the clinicians in consistently delivering high-quality consultations with essential documentation and consenting as well as secure data storage. It also provides complete data transparency, allowing patients access to their notes online and sharing among clinicians.
By using blockchain technology, the iConsult platform provides another world first in aesthetics, ensuring the highest data security for patients and clinicians. The Cosmecoin offers patients loyalty rewards which, unlike other reward point systems, are likely to be used as they won’t be restricted to practices.
Because of these two principles of ensuring high-quality consultations, secure documentation and a practical loyalty rewards system I am delighted to be part of the iConsult and Cosmecoin team.”
Dr Ravi Jain, LinkedIn: https://www.linkedin.com/in/drravijain/
Dr Ravi Jain, Twitter: https://twitter.com/DrRaviJain
DISCLAIMER:
Neither this document nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Any offer to acquire tokens will be made, and any investor should make its investment decision solely on the basis of the information that is contained in the information memorandum to be published by iConsult Software Ltd in due course in connection. Copies of the information memorandum will, following publication, be available at www.cosmecoin.io.
These materials are not an offer of securities for sale in the United States. The securities to which these materials relate have not been registered under the US Securities Act of 1933, as amended (the “Securities Act”) or the securities laws of any state or jurisdiction of the United States. Accordingly, these securities may not be, sold, pledged, assigned, delivered or otherwise transferred, exercised or redeemed, at any time, within the United States or to, or for the account or benefit of, U.S. Persons. There will be no public offering of the securities in the United States.
